norfloxacin has been researched along with Enteritis in 15 studies
Norfloxacin: A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.
norfloxacin : A quinolinemonocarboxylic acid with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase.
Enteritis: Inflammation of any segment of the SMALL INTESTINE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Norfloxacin has great potential for the treatment of bacterial enteric infections reflected by its broad in vitro activity as well as its effectiveness in initial clinical trials." | 2.37 | Norfloxacin in the treatment of bacterial enteric infections. ( Ruiz-Palacios, GM, 1986) |
| "Norfloxacin has a well proven efficacy in UTI but remains to be proven in enteric infections." | 2.37 | Principles for targeted antibiotic use in urinary tract and enteric infections: a review with special emphasis on norfloxacin. ( Norrby, SR, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (46.67) | 18.7374 |
| 1990's | 6 (40.00) | 18.2507 |
| 2000's | 2 (13.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cristiano, P | 1 |
| Menon, S | 1 |
| Fukuyama, M | 2 |
| Kawakami, K | 1 |
| Suda, O | 1 |
| Imagawa, Y | 1 |
| Deguchi, K | 1 |
| Suzuki, Y | 1 |
| Ishihara, R | 1 |
| Ishii, Y | 1 |
| Nakazawa, A | 1 |
| Furuhata, K | 1 |
| Oonaka, K | 1 |
| Hara, T | 1 |
| Sunakawa, K | 1 |
| Fujii, R | 1 |
| Meguro, H | 1 |
| Arimasu, O | 1 |
| Ushijima, K | 1 |
| Abe, T | 1 |
| Nakazawa, S | 1 |
| Sato, H | 1 |
| Narita, A | 1 |
| Niino, K | 1 |
| Ichihashi, H | 1 |
| Kuno, K | 1 |
| Ogawa, A | 1 |
| Nakao, Y | 1 |
| Hayakawa, F | 1 |
| Ando, Y | 1 |
| Kito, O | 1 |
| Minamitani, M | 1 |
| Hachimori, K | 1 |
| Kaneda, K | 1 |
| Ihara, T | 1 |
| Kawaguchi, H | 1 |
| Ito, M | 1 |
| Kamiya, H | 1 |
| Sakurai, M | 1 |
| Murray, BE | 1 |
| Aoki, T | 2 |
| Shimizu, N | 2 |
| Tomizawa, I | 2 |
| Takizawa, Y | 2 |
| Matsubara, Y | 2 |
| Seo, T | 2 |
| Sagara, H | 2 |
| Tagawa, K | 2 |
| Masuda, G | 2 |
| Negishi, M | 2 |
| Goto, N | 1 |
| Horiuchi, S | 1 |
| Okamura, N | 1 |
| Inagaki, Y | 1 |
| Ozawa, K | 1 |
| Mochizuki, A | 1 |
| Nakaya, R | 1 |
| Ruiz-Palacios, GM | 1 |
| Norrby, SR | 1 |
3 reviews available for norfloxacin and Enteritis
| Article | Year |
|---|---|
Quinolones and the gastrointestinal tract.
Topics: Agranulocytosis; Anti-Infective Agents; Bacterial Infections; Biliary Tract Diseases; Diarrhea; Drug | 1989 |
Norfloxacin in the treatment of bacterial enteric infections.
Topics: Bacterial Infections; Diarrhea; Enteritis; Humans; Norfloxacin | 1986 |
Principles for targeted antibiotic use in urinary tract and enteric infections: a review with special emphasis on norfloxacin.
Topics: Bacterial Infections; Drug Resistance, Microbial; Enteritis; Humans; Norfloxacin; Urinary Tract Infe | 1986 |
2 trials available for norfloxacin and Enteritis
| Article | Year |
|---|---|
[Evaluation of norfloxacin in the pediatric field. Pediatric Study Group for Norfloxacin].
Topics: Administration, Oral; Bacterial Infections; Campylobacter Infections; Child; Child, Preschool; Drug | 1990 |
[Comparison of clinical efficacy of norfloxacin (NFLX) and pipemidic acid (PPA) in the treatment of infectious enteritis by a double-blind method. The Japan Research Committee of Norfloxacin Research Group Enteritis].
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Dysentery, | 1987 |
10 other studies available for norfloxacin and Enteritis
| Article | Year |
|---|---|
Clinical trial of norfloxacin in the treatment of bacterial enteritis.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Clinical Trials as Topic; Enteritis; Femal | 1989 |
Primary prophylaxis of SBP.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Drug Resistance, Bacterial; Enteritis; Enterocoliti | 2008 |
[In vitro antibacterial activity of balofloxacin (BLFX) against isolates from patients with bacterial enteritis].
Topics: Anti-Infective Agents; Drug Resistance, Microbial; Enteritis; Enterobacteriaceae Infections; Escheri | 1995 |
[The drug susceptibility pattern of the presumed etiologic agents of infectious enteritis including verotoxin-producing Escherichia coli O-157].
Topics: Aerobiosis; Ampicillin; Anaerobiosis; Anti-Bacterial Agents; Anti-Infective Agents; Campylobacter je | 1997 |
[Antibacterial activity of fosfomycin against the causative bacteria isolated from bacterial enteritis].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Blood; Campylobacter; Electrolyt | 2000 |
[Bacteriological and clinical studies on norfloxacin in the field of pediatrics].
Topics: Administration, Oral; Adolescent; Age Factors; Bacteria; Child; Child, Preschool; Drug Evaluation; D | 1990 |
[Clinical study on norfloxacin in pediatrics].
Topics: Adolescent; Age Factors; Campylobacter Infections; Child; Child, Preschool; Drug Evaluation; Dysente | 1990 |
[Clinical evaluation of norfloxacin in children].
Topics: Adolescent; Age Factors; Bacteria; Child; Child, Preschool; Drug Evaluation; Drug Resistance, Microb | 1990 |
[Clinical study of AM-715 on acute infectious enteritis. The Japan Research Committee of AM-715, Research Group for Acute Infectious Enteritis].
Topics: Acute Disease; Administration, Oral; Campylobacter Infections; Drug Administration Schedule; Dysente | 1986 |
[In vitro antibacterial activity of norfloxacin (NFLX) against enteritis-causing bacteria].
Topics: Campylobacter; Drug Resistance, Microbial; Enteritis; Enterobacteriaceae; Escherichia coli; Humans; | 1986 |